Revenue Improved 539% and Gross Profit Improved 487% compared to the three months ended June 30, 2016 CHICAGO, IL- - August 15, 2017 - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced financial results for the quarter ended June 30, 2017. For the quarter ended June 30, 2017, versus the quarter ended June 30, 2016, Cosmos Holdings' revenue improved 539% to $6.1 million from $955 thousand. The increase was mainly on the strength of its SkyPharm SA subsidiary, ...

Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016 For the quarter ended March 31, 2017, versus the quarter ended March 31, 2016, Cosmos Holdings’ revenue improved 262% to $4.1 million from $1.1 million on the strength of its SkyPharm SA subsidiary, which obtained the necessary capital during 2016 and 2017 in order to develop, expand and organically grow its operations. Of note, revenue improved sequentially 27%, from $3.2 million in the 2016 ...

Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016 For the quarter ended March 31, 2017, versus the quarter ended March 31, 2016, Cosmos Holdings' revenue improved 262% to $4.1 million from $1.1 million on the strength of its SkyPharm SA subsidiary, which obtained the necessary capital during 2016 and 2017 in order to develop, expand and organically grow its operations. Of note, revenue improved sequentially 27%, from $3.2 million in the 2016 ...

Cosmos Holdings Inc. reported strong revenue growth in the fourth quarter of 2016 over the previous quarter. Sales increased from $1,414,000 to $3,070,000 from Q3 2016 to Q4 2016, respectively, an over 110% improvement. The increase was due to organic growth in sales from the Company’s subsidiary Sky Pharm SA. Cosmos Holdings had revenue for the full year ended December 31, 2016, of $6,755,436, versus $533,802 for the full year ended December 31, 2015. During 2016, revenues increased over ...

CHICAGO, IL - (Marketwired - Feb 14, 2017) - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that the Company acquired 100% of the shares of Decahedron Ltd, a privately held company located in Harlow, United Kingdom just north of London. Decahedron Ltd. is a pharmaceutical wholesaler incorporated in the UK in August 2011 and it is audited by the MHRA (Medicines and Healthcare Products Regulatory Agency) under European GDP (Good Distribution Practices). Decahedron is ...